EP3247707
4-Metýlsúlfónýl-setin píperidín-úrea-efnasambönd sem eru nytsamleg til meðhöndlunar á hjartaröskunum eins og hjartavöðvakvilla með ofþenslu (DCM)
Status:
EP einkaleyfi í gildi á ÍslandiEP appl. date:
21.1.2016EP published:
31.5.2023EP application number:
16702652.5
EP translation filed:
14.8.2023Grant published:
15.9.2023EPO information:
European Patent Register
Max expiry date:
20.1.2036Expiry date:
20.1.2027Next due date:
31.1.2027
Title in English:
4-METHYLSULFONYL-SUBSTITUTED PIPERIDINE UREA COMPOUNDS USEFUL FOR THE TREATMENT OF CARDIAC DISORDERS SUCH AS DILATED CARDIOMYOPATHY (DCM)Language of the patent:
English
Timeline
Today
21.1.2016EP application
31.5.2023EP Publication
14.8.2023Translation submitted
15.9.2023Registration published
20.1.2027Expires
Owner
Name:
MyoKardia, Inc.Address:
1000 Sierra Point Parkway, Brisbane, CA 94005, US
Inventor
Name:
OSLOB, JohanAddress:
California 94005, US
Name:
AUBELE, DanielleAddress:
California 94005, US
Name:
KIM, JaeAddress:
California 94005, US
Name:
MCDOWELL, RobertAddress:
California 94005, US
Name:
SONG, YonghongAddress:
California 94005, US
Name:
SRAN, ArvinderAddress:
California 94005, US
Name:
ZHONG, MinAddress:
California 94005, US
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113, Reykjavík,
Priority
Number:
201562106571 PDate:
22.1.2015Country:
US
Classification
Categories:
C07D 401/14, C07D 401/02, C07D 407/02, C07D 407/14, C07D 409/02, C07D 411/14, C07D 471/04, A61K 31/435, A61P 9/04
Annual fees
Number
Paid
Expires
Payer
Number: 9
Paid: 18.12.2023
Expires: 20.1.2025
Payer: Árnason Faktor ehf.
Number: 10
Paid: 10.12.2024
Expires: 20.1.2026
Payer: Árnason Faktor ehf.
Number: 11
Paid: 13.1.2026
Expires: 20.1.2027
Payer: Árnason Faktor ehf.